Activation and Regulation of Indirect Alloresponses in Transplanted Patients With Donor Specific Antibodies and Chronic Rejection
Transplant International · 2024
DOI: 10.3389/ti.2024.13196 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transplant International, 2024. Verfasst von Sumoyee Basu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Nephrology, Urology and Transplantation, King's College London, London, United Kingdom. Hauptthemen laut MEDLINE: Graft Rejection, Isoantibodies, B-Lymphocytes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Following transplantation, human CD4+T cells can respond to alloantigen using three distinct pathways. Direct and semi-direct responses are considered potent, but brief, so contribute mostly to acute rejection. Indirect responses are persistent and prolonged, involve B cells as critical antigen presenting cells, and are an absolute requirement for development of donor specific antibody, so more often mediate chronic rejection. Novel in vitro techniques have furthered our understanding by mimicking in vivo germinal centre processes, including B cell antigen presentation to CD4 + T cells and effector cytokine responses following challenge with donor specific peptides. In this review we outline recent data detailing the contribution of CD4 + T follicular helper cells and antigen presenting B cells to donor specific antibody formation and antibody mediated rejection. Furthermore, multi-parametric flow cytometry analyses have revealed specific endogenous regulatory T and B subsets each capable of suppressing distinct aspects of the indirect response, including CD4 + T cell cytokine production, B cell maturation into plasmablasts and antibody production, and germinal centre maturation. These data underpin novel opportunities to control these aberrant processes either by targeting molecules critical to indirect alloresponses or potentiating suppression via exogenous regulatory cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Nephrology, Urology and Transplantation, King's College London, London, United Kingdom.
- Department of Inflammation Biology, King's College London, London, United Kingdom.
- Transplantation, Renal and Urology Directorate, Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, United Kingdom.
- Renal Unit, King's College Hospital NHS Foundation Trust, London, United Kingdom.
- Liver Sciences, King's College London, London, United Kingdom.
Förderung
- Medical Research Council
Zitieren
APA
Basu, S., Dudreuilh, C., Shah, S., Sanchez-Fueyo, A., Lombardi, G., & Dorling, A. (2024). Activation and Regulation of Indirect Alloresponses in Transplanted Patients With Donor Specific Antibodies and Chronic Rejection. Transplant International. https://doi.org/10.3389/ti.2024.13196
Vancouver
Basu S, Dudreuilh C, Shah S, Sanchez-Fueyo A, Lombardi G, Dorling A. Activation and Regulation of Indirect Alloresponses in Transplanted Patients With Donor Specific Antibodies and Chronic Rejection. Transplant International. 2024. doi:10.3389/ti.2024.13196
BibTeX
@article{Basu2024,
author = {Basu, Sumoyee and Dudreuilh, Caroline and Shah, Sapna and Sanchez-Fueyo, Alberto and Lombardi, Giovanna and Dorling, Anthony},
title = {Activation and Regulation of Indirect Alloresponses in Transplanted Patients With Donor Specific Antibodies and Chronic Rejection},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2024.13196}
}
EUVIMED